Form 4 for BSX Boston Scientific
Accepted 2025-02-13 00:00:00 ET · period of report 2024-12-03 · accession 0001225208-25-001683 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-13 | 2025-02-11 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $105.98 | -14.4K | 172.9K | -8% | -$1.53M | |
| 2025-02-13 | 2025-02-11 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | A - Grant | $0.00 | +31.7K | 187.3K | +20% | $0 | |
| 2025-02-13 | 2024-12-10 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale | $89.97 | -20 | 148.1K | -0.0% | -$1,799 | |
| 2025-02-13 | 2024-12-03 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | P - Purchase | $90.29 | +50 | 148.2K | +0.0% | +$4,514 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-11 | F | D | 14,447 | $105.98 | 172,863 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-11 | A | A | 31,680 | $0.00 | 187,310 | D | — | — | |
| 3 | Common | Common Stock | 2024-12-10 | S | D | 20 | $89.97 | 148,148 | D | — | — | |
| 4 | Common | Common Stock | 2024-12-03 | P | A | 50 | $90.29 | 148,168 | D | — | — |